Reuben Antony, M.D.

Associate Professor, Division of Clinical Pediatrics

To see if Reuben Antony is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).



Pediatric Hematology/Oncology




Locations and Contact

Hematology/Oncology Clinic

4501 X Street
Sacramento, CA 95817

Get Directions

Additional Numbers

Physician Referrals

800-4-UCDAVIS (800-482-3284)

Philosophy of Care

In the last decade we have gained many new and exciting insights into the mechanistic basis of childhood CNS malignancies. Everyday I aim to provide compassionate and cutting edge care to the children and families who have placed their trust in us.

Clinical Interests

Dr. Antony offers care to children with tumors of the Central Nervous System and to children with Cancer Predisposition Syndromes.


Pediatric Hematology/Oncology

Center/Program Affiliation

UC Davis Children's Hospital

Medical School

M.B.B.S., St. Johns Medical College, Bangalore, India 1996


Pediatrics, New York Medical College, New York NY 2006-2008


Pediatric Hematology and Oncology, Children's Hospital of Los Angeles, Los Angeles CA 2008-2011


Pediatric Hematology and Oncology, Great Ormond Street Hospital for Sick Children, London, UK 2001-2003


Pediatric Hematology and Oncology, Hospital for Sick Children, Toronto, Ontario, Canada 2005-2006

Pediatric Subspecialty Teaching Award Nominee (one of five nominated pediatricians), 2016

Outstanding Pediatric Faculty (Clinical, Academic, Research) nominee (one of five nominated), 2015

Pediatric Subspecialty Teaching Award Nominee (one of five nominated pediatricians), 2015

Best Teacher Award (Dept. of Pediatrics), University of Illinois College of Medicine (UICOMP), 2014

Speckhart BA, Bugaieski E, Antony R, Fernandez KS. Rituximab and intense chemotherapy in a patient with defective cell mediated immunity due to cartilage-hair hypoplasia and Burkitt lymphoma. Pediatr Blood Cancer. 2020;67(7):e28259. doi:10.1002/pbc.28259

Mondal G, Lee JC, Ravindranathan A, et al. Pediatric bithalamic gliomas have a distinct epigenetic signature and frequent EGFR exon 20 insertions resulting in potential sensitivity to targeted kinase inhibition. Acta Neuropathol. 2020;139(6):1071-1088. doi:10.1007/s00401-020-02155-5,

Goodarzi A, Garza N, Lechpammer M, Anthony R, Zwienenberg M. The molecular oncology of bilateral high-grade thalamic astrocytomas in children. Childs Nerv Syst. 2019;35(11):2047-2054. doi:10.1007/s00381-019-04372-0.

Fernández KS, Antony R, Kumar A. Patients with "ALPS-like phenotype" diagnosed with immune dysregulation due to LRBA deficiency. Pediatr Blood Cancer. 2019;66(3):e27558. doi:10.1002/pbc.27558.

Kramer M, Antony R, Ozturk A, Lehn K, Graff JP, Chung JH. A Palpable Back Mass as First Presenting Sign of Acute Lymphoblastic Leukemia in a Pediatric Patient. J Pediatr Hematol Oncol. 2019 Jan;41(1):77-78. doi:10.1097/MPH.0000000000001214.

McCarthy LC, Fernandez KS, Antony R. Challenges in the Diagnosis and Management of Pediatric Hemophagocytic Lymphohistiocytosis. Clin Pediatr (Phila). 2018 Aug;57(9):1107-1113. doi:10.1177/0009922817735997.

Gnanamony M, Antony R, Fernández KS, Jaime L, Lin J, Joseph PA, Gondi CS. Chronic radiation exposure of neuroblastoma cells reduces nMYC copy number. Oncol Lett. 2017 Sep;14(3):3363-3370.

Duong C, Yoshida S, Chen C, Barisone G, Diaz E, Li Y, Beckett L, Chung J, Antony R, Nolta J, Nitin N, Satake N. Novel targeted therapy for neuroblastoma: silencing the MXD3 gene using siRNA. Pediatr Res. 2017 Sep;82(3):527-535.

Tanpure S, Boyineini J, Gnanamony M, Antony R, Fernández KS, Libes J, Lin J, Pinson D, Joseph PA, Gondi CS. SPARC overexpression suppresses radiation-induced HSP27 and induces the collapse of mitochondrial Δψ in neuroblastoma cells. Oncol Lett. 2017 Jun;13(6):4602-4610.

Boyineni J, Tanpure S, Gnanamony M, Antony R, Fernández KS, Lin J, Pinson D, Gondi CS. SPARC overexpression combined with radiation retards angiogenesis by suppressing VEGF-A via miR 410 in human neuroblastoma cells. Int J Oncol. 2016 Oct;49(4):1394-406.